Curis (CRIS) Interest Coverage Ratio (2011 - 2026)
Curis' (CRIS) quarterly Interest Coverage Ratio came in at 38.4 in Q1 2026, down 108.67% YoY from 442.69 in Q1 2025, and down 161.45% on a QoQ basis from 62.48 in Q4 2025.
Curis (CRIS) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Curis (CRIS) has 16 years of Interest Coverage Ratio data on file, last reported at 38.4 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 108.67% year-over-year to 38.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.66 (up 93.82% YoY) and the FY2025 annual result came in at 0.03, up 87.28% from the prior year.
- Interest Coverage Ratio retreated to 38.4 in Q1 2026, from 62.48 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 77.21 in Q4 2023 to a low of 38.4 in Q1 2026.
- A 5-year average of 7.21 and a median of 17.59 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio tumbled 127.99% — and 2023, when it jumped 1347.28%.
- Tracing CRIS's Interest Coverage Ratio over 5 years: stood at 6.19 in 2022, then jumped by 1347.28% to 77.21 in 2023, then sank by 81.77% to 14.08 in 2024, then soared by 343.91% to 62.48 in 2025, then slumped by 161.45% to 38.4 in 2026.
- The last three Interest Coverage Ratio figures came in at 38.4 (Q1 2026), 62.48 (Q4 2025), and 7.82 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Curis | 3.44 Mn | -2.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.40 |
| Dec 31, 2025 | 62.48 |
| Sep 30, 2025 | -7.82 |
| Jun 30, 2025 | -19.01 |
| Mar 31, 2025 | -18.40 |
| Dec 31, 2024 | 14.08 |
| Sep 30, 2024 | -26.42 |
| Jun 30, 2024 | -31.28 |
| Mar 31, 2024 | -31.17 |
| Dec 31, 2023 | 77.21 |
| Sep 30, 2023 | -19.98 |
| Jun 30, 2023 | -19.03 |
| Mar 31, 2023 | -17.59 |
| Dec 31, 2022 | -6.19 |
| Sep 30, 2022 | -12.32 |
| Jun 30, 2022 | -14.47 |
| Mar 31, 2022 | -14.33 |
| Dec 31, 2021 | -11.36 |
| Sep 30, 2021 | -9.51 |
| Jun 30, 2021 | -9.38 |